Clinical Trials Browser

Terminated × Thalidomide × Genitourinary × Clear all

NCT00090870 2018-07-12

PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer

Phase 2 Terminated

10 enrolled 4 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00450008 2016-03-17

Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms